Diabetes, Obesity, and the Brain

Recent evidence suggests a key role for the brain in the control of both body fat content and glucose metabolism. Neuronal systems that regulate energy intake, energy expenditure, and endogenous glucose production sense and respond to input from hormonal and nutrient-related signals that convey information regarding both body energy stores and current energy availability. In response to this input, adaptive changes occur that promote energy homeostasis and the maintenance of blood glucose levels in the normal range. Defects in this control system are implicated in the link between obesity and type 2 diabetes.

[1]  M. White.  Insulin Signaling in Health and Disease , 2003, Science.

[2]  B. Corkey,et al.  Fatty acid metabolism and insulin secretion in pancreatic beta cells , 2003, Diabetologia.

[3]  S. Woods,et al.  Monitoring of stored and available fuel by the CNS: implications for obesity , 2003, Nature Reviews Neuroscience.

[4]  M. Maffei,et al.  Positional cloning of the mouse obese gene and its human homologue , 1994, Nature.

[5]  J. Papp,et al.  Identification of the gene altered in Berardinelli–Seip congenital lipodystrophy on chromosome 11q13 , 2001, Nature Genetics.

[6]  F. Raal,et al.  From lipodystrophy syndromes to diabetes mellitus , 2001, The Lancet.

[7]  S. D. de Boer,et al.  Hypothalamic, Metabolic, and Behavioral Responses to Pharmacological Inhibition of CNS Melanocortin Signaling in Rats , 2001, The Journal of Neuroscience.

[8]  D. Porte,et al.  Clinical importance of insulin secretion and its interaction with insulin resistance in the treatment of type 2 diabetes mellitus and its complications. , 2001, Diabetes/metabolism research and reviews.

[9]  S. Woods,et al.  Insulin in the brain: a hormonal regulator of energy balance. , 1992, Endocrine reviews.

[10]  G. Shulman,et al.  On Diabetes: Insulin Resistance Cellular Mechanisms of Insulin Resistance , 2022 .

[11]  Zhaohui Feng,et al.  Central administration of oleic acid inhibits glucose production and food intake. , 2002, Diabetes.

[12]  M. Lane,et al.  Hypothalamic malonyl-CoA as a mediator of feeding behavior , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[13]  Roberto Conti,et al.  Inhibition of hypothalamic carnitine palmitoyltransferase-1 decreases food intake and glucose production , 2003, Nature Medicine.

[14]  R. Seeley,et al.  Insulin activation of phosphatidylinositol 3-kinase in the hypothalamic arcuate nucleus: a key mediator of insulin-induced anorexia. , 2003, Diabetes.

[15]  M. Schwartz,et al.  Adiposity signaling and biological defense against weight gain: absence of protection or central hormone resistance? , 2004, The Journal of clinical endocrinology and metabolism.

[16]  J. L. Marks,et al.  Intracerebroventricular Neuropeptide Y Acutely Influences Glucose Metabolism and Insulin Sensitivity in the Rat , 1997, Journal of neuroendocrinology.

[17]  Rüdiger Klein,et al.  Role of Brain Insulin Receptor in Control of Body Weight and Reproduction , 2000 .

[18]  H. Pijl,et al.  Intracerebroventricular neuropeptide Y infusion precludes inhibition of glucose and VLDL production by insulin. , 2004, Diabetes.

[19]  D. Hardie.  Printed in U.S.A. Copyright © 2003 by The Endocrine Society doi: 10.1210/en.2003-0982 Minireview: The AMP-Activated Protein Kinase Cascade: The Key Sensor of Cellular Energy Status , 2022 .

[20]  Kanji A. Takahashi,et al.  The anorexigenic fatty acid synthase inhibitor, C75, is a nonspecific neuronal activator. , 2004, Endocrinology.

[21]  M. Prentki,et al.  Metabolic control of -cell function , 2000 .

[22]  Å. Lindström,et al.  Ornithology: Arctic waders are not capital breeders , 2001, Nature.

[23]  R. Cone,et al.  The Central Melanocortin System and Energy Homeostasis , 1999, Trends in Endocrinology & Metabolism.

[24]  C. Kahn,et al.  Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms , 2004, Molecular and Cellular Biology.

[25]  S. Woods,et al.  Central nervous system control of food intake , 2000, Nature.

[26]  A. Yoshimura,et al.  Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity , 2004, Nature Medicine.

[27]  M. Birnbaum,et al.  AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus , 2004, Nature.

[28]  S. Woods,et al.  Leptin Increases Hypothalamic Pro-opiomelanocortin mRNA Expression in the Rostral Arcuate Nucleus , 1997, Diabetes.

[29]  S. Woods,et al.  Chronic intracerebroventricular infusion of insulin reduces food intake and body weight of baboons , 1979, Nature.

[30]  S. O’Rahilly,et al.  Congenital leptin deficiency is associated with severe early-onset obesity in humans , 1997, Nature.

[31]  S. Kalra,et al.  Neuropeptide Y stimulates feeding but inhibits sexual behavior in rats. 1985. , 1985, Obesity research.

[32]  J. Flier,et al.  Enhanced leptin sensitivity and attenuation of diet-induced obesity in mice with haploinsufficiency of Socs3 , 2004, Nature Medicine.

[33]  C. Kahn,et al.  Suppressor of Cytokine Signaling 1 (SOCS-1) and SOCS-3 Cause Insulin Resistance through Inhibition of Tyrosine Phosphorylation of Insulin Receptor Substrate Proteins by Discrete Mechanisms , 2005, Molecular and Cellular Biology.

[34]  M. Low,et al.  Leptin activates anorexigenic POMC neurons through a neural network in the arcuate nucleus , 2001, Nature.

[35]  S. Woods,et al.  Specificity of Leptin Action on Elevated Blood Glucose Levels and Hypothalamic Neuropeptide Y Gene Expression in ob/ob Mice , 1996, Diabetes.

[36]  G. Barsh,et al.  Antagonism of central melanocortin receptors in vitro and in vivo by agouti-related protein. , 1997, Science.

[37]  Steven R Smith,et al.  A leptin dose-response study in obese (ob/ob) and lean (+/?) mice. , 1998, Endocrinology.

[38]  J. Shutter,et al.  Hypothalamic expression of ART, a novel gene related to agouti, is up-regulated in obese and diabetic mutant mice. , 1997, Genes & development.

[39]  C. Townsend,et al.  Reduced food intake and body weight in mice treated with fatty acid synthase inhibitors. , 2000, Science.

[40]  M. Reitman,et al.  Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes. , 2001, Diabetes.

[41]  M. Myers,et al.  The role of leptin→STAT3 signaling in neuroendocrine function: an integrative perspective , 2004, Journal of Molecular Medicine.

[42]  S. O’Rahilly,et al.  Genotype-phenotype relationships in Berardinelli-Seip congenital lipodystrophy , 2002, Journal of medical genetics.

[43]  M. Reitman,et al.  Leptin-replacement therapy for lipodystrophy. , 2002, The New England journal of medicine.

[44]  R. Gruetter,et al.  The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. , 2001, Diabetes.

[45]  G. Ronnett,et al.  C75, a Fatty Acid Synthase Inhibitor, Reduces Food Intake via Hypothalamic AMP-activated Protein Kinase* , 2004, Journal of Biological Chemistry.